BetterLife’s Non-Hallucinogenic LSD Derivative Clears Safety Hurdle

May 15, 2024

Lykos Therapeutics: FDA Set to Review MDMA for PTSD Treatment

May 9, 2024

Compass Pathways COMP360 Delivers on Phase 2 Results

May 9, 2024

Psychedelics Without the Trip Show Antidepressant Potential

May 9, 2024

Talking Psychedelic-Assisted Therapy With Ricky Williams

May 7, 2024

Preserving a Legacy: Wendy Tucker’s Vision for Shulgin Farm

April 26, 2024